Show notes
Episode SummaryAnish Koka and Anthony DiGiorgio sit down with Martin Shkreli — the former hedge fund manager and pharma executive best known for the 2015 Daraprim price increase and his subsequent prison sentence — for a wide-ranging conversation on drug pricing, patent law, and the state of the pharmaceutical industry. Shkreli walks through his path from a teenage hedge fund intern to founding Retrophin and Turing Pharmaceuticals, defends orphan drug economics and the Orphan Drug Act's seven-year exclusivity window, and argues that patent terms haven't kept pace with the realities of modern drug development. The conversation turns to the Chemocentrics/Amgen scandal — in which trial data for a rare vasculitis drug was allegedly unblinded, manipulated, and relocked to manufacture statistical significance — which Shkreli calls one of the worst frauds in the history of medicine. The episode closes with discussion of the Sarepta/DMD approval controversy, the limits of randomized trials in surgery and rare disease, AI's parallels to neuroscience, and the state of media coverage of the FDA.Chapter Markers00:00 Intro and Martin Shkreli's backstory02:40 Origin story: from hedge fund to founding drug companies07:58 The Daraprim price increase and Shkreli's pricing philosophy17:14 What it actually takes to bring a drug to market35:25 The case for the pharmaceutical industry38:00 The Orphan Drug Act and patent exclusivity57:31 The Chemocentrics scandal: manipulated trial data at Amgen1:22:09 Vinay Prasad, Sarepta, and the DMD approval fights1:34:35 Neurosurgery, clinical trials, and the limits of RCTs1:37:30 AI, neural networks, and the future of psychiatric drugs1:40:40 Cardiovascular disease and LDL lowering1:42:28 Media coverage of the FDA and closing thoughtsCo-Host Handles@anish_koka and @drdigiorgioShow Handles@drsloungepodSubscribe LinksSpotify: https://open.spotify.com/show/44vw8eirsKKnjgNIrdDvrRApple Podcasts: https://podcasts.apple.com/us/podcast/the-doctors-lounge/id1832097658YouTube: https://www.youtube.com/@TheDoctorsLoungePod